The table below summarizes the most recent Palisade Bio insider buying information, with links below the price to see the CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more information about why Palisade Bio insider buys are important for investors to follow.

Date	Insider	Price	Amount
2-6-2024 Insider Buy	John David Finley CEO, CFO, Director	$0.47 CAGR »	$4,692.00 10,000 shares
1-31-2024 Insider Buy	Donald Allen Williams Director	$0.60 CAGR »	$6,050.00 10,000 shares
1-31-2024 Insider Buy	John David Finley CEO, CFO, Director	$0.56 CAGR »	$5,590.00 10,000 shares
9-27-2023 Insider Buy	John David Finley CEO, CFO, Director	$0.54 CAGR »	$8,088.00 15,000 shares
9-27-2023 Insider Buy	Donald Allen Williams Director	$0.54 CAGR »	$10,800.00 20,000 shares
9-13-2023 Insider Buy	John David Finley CEO, CFO, Director	$0.66 CAGR »	$9,825.00 15,000 shares
9-1-2022 Insider Buy	John David Finley Chief Financial Officer	$0.14 CAGR »	$2,799.45 19,481 shares
8-23-2022 Insider Buy	John David Finley Chief Financial Officer	$0.16 CAGR »	$1,176.00 7,350 shares
8-16-2022 Insider Buy	John David Finley Chief Financial Officer	$0.25 CAGR »	$25,000.00 100,000 shares
8-16-2022 Insider Buy	Thomas Hallam Chief Executive Officer	$0.25 CAGR »	$10,000.00 40,000 shares
3-29-2022 Insider Buy	Michael John Dawson Chief Medical Officer	$1.14 CAGR »	$17,092.50 15,000 shares
3-28-2022 Insider Buy	Thomas Hallam Chief Executive Officer	$1.18 CAGR »	$11,800.00 10,000 shares
3-24-2022 Insider Buy	John David Finley Chief Financial Officer	$1.09 CAGR »	$8,174.25 7,500 shares
9-21-2021 Insider Buy	Thomas Hallam Chief Executive Officer	$2.49 CAGR »	$14,940.00 6,000 shares
9-21-2021 Insider Buy	John David Finley Chief Financial Officer	$2.44 CAGR »	$4,880.00 2,000 shares
9-10-2021 Insider Buy	Robert J. Trenschel Director	$2.82 CAGR »	$42,297.12 14,999 shares
8-27-2021 Insider Buy	John David Finley Chief Financial Officer	$2.65 CAGR »	$26,468.00 10,000 shares

Also See: Institutional Holders of PALI
Also See: SEC filings

Below we present the annualized performance delivered by Palisade Bio stock since 2-6-2024 (the date of the most recent insider purchase). The performance of the investment from the time Palisade Bio insider buying occurred is the ultimate test of whether insiders were right about PALI being a good buy.

Growth of $10,000.00 Without Dividends Reinvested
Start date:	02/07/2024
End date:	04/30/2024
Start price/share:	$6.75
End price/share:	$6.03
Dividends collected/share:	$0.00
Total return:	-10.67%
Annualized Gain:	-47.48%
Starting investment:	$10,000.00
Ending investment:	$8,933.00
Years:	0.22

Palisade Bio Insider Buying

This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent Palisade Bio insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).

Also See: Funds Holding PALI

PALI — Current Quote

Quotes delayed 20 minutes

Free PALI Email Alerts:
Get Dividend Alerts

Get SEC Filing Alerts

PALI — Performance

More Insider Buying

Other companies seeing insider buying close in time to when the Palisade Bio Insider Buying occurred are:

UroGen Pharma Insider Buying
Occidental Petroleum Insider Buying
Better Choice Insider Buying
CNS Pharmaceuticals Insider Buying
Spire Insider Buying
Provident Financial Services Insider Buying
Veralto Insider Buying
AFLAC Insider Buying
Arrow Financial Insider Buying
GeoVax Labs Insider Buying

Palisade Bio Insider Buying

Palisade Bio Insider Buying | www.HoldingsChannel.com